Structural mimics of RGD-binding sites

Details Structural mimics of RGD-binding sites Structural mimics of RGD-binding sites

1998-05-14

1999-09-21

Tsang, Cecilia J.

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

Cyclic peptides

514 9, 514 11, C07K 706, C07K 764

Patent

active

059555726

ABSTRACT:
The present invention provides cyclic peptides that recognize the arginine-glycine-aspartic acid (RGD) motif characteristic of many integrin ligands. These cyclic RGD-binding peptides, which comprise the motif (W/P)DD(G/L)(W/L)(W/L/M), have a structure that functionally mimics the RGD-binding site on an integrin. The invention further provides an antibody selectively reactive with a cyclic RGD-binding peptide containing the sequence (W/P)DD(G/L)(W/L)(W/L/M). The invention also provides a method to reduce or inhibit cell attachment to an RGD-containing ligand using a cyclic RGD-binding peptide of the invention.

REFERENCES:
patent: 5149780 (1992-09-01), Plow et al.
patent: 5192746 (1993-03-01), Lobl et al.
patent: 5204445 (1993-04-01), Plow et al.
patent: 5536814 (1996-07-01), Ruoslahti et al.
McMurray et al., Tetrahedron Letters, 34:8059-8062 (1993).
Pasqualini et al., "A Peptide Isolated from Phage Display Libraries Is a Structural and Functional Mimic of an RGD-binding Site on Integrins," J. Cell Biol. 130:1189-1196 (1995).
Pasqualini et al., "Determination of the Putative Binding Site for Fibronectin on Platelet Glycoprotein IIb-IIIa Complex through a Hydropathic Complementarity Approach," J. Biol. Chem. 264:14566-14570 (1989).
Pierschbacher et al., "Influence of Stereochemistry of the Sequence Arg-Gly-Asp-Xaa on Binding Specificity in Cell Adhesion," J. Biol. Chem. 262:17294-17298 (1987).
Pfaff et al., "Comparison of Disintegrins with Limited Variation in the RGD Loop in Their Binding to Purified Integrins .alpha.IIb.beta.3, .alpha.v.beta.3 and .alpha.5.beta.1 and in Cell Adhesion Inhibition,"Cell Adhesion and Communication 2:491-501 (1994).
Smith and Cheresh, "Integrin (.alpha..sub.v .beta..sub.3)-Ligand Interaction," J. Biol. Chem. 265:2168-2172 (1990).
Smith and Cheresh, "The Arg-Gly-Asp Binding Domain of the Vitronectin Receptor," J. Biol. Chem. 263:18726-18731 (1988).
Steiner et al., "Ca.sup.2+ -dependent Binding of a Synthetic Arg-Gly-Asp (RGD) Peptide to a Single Site on the Purified Platelet Glycoprotein Iib-IIIa Complex," J. Biol. Chem. 264:13102-13108 (1989).
Takada et al., "A Point Mutation of Integrin .beta..sub.1 Subunit Blocks Binding of .alpha..sub.5 .beta..sub.1 to Fibronectin and Invasin but not Recruitment to Adhesion Plaques," J. Cell Biol. 119:913-921 (1992).
Cierniewski et al., "Characterization of Cation-Binding Sequences in the Platelet Integrin GPIIb-IIIa (.varies..sub.Iib .beta..sub.3) by Terbium Luminescence," Biochemistry 33:12238-12246 (1994).
D'Souza et al., "Ligand and Cation Binding Are Dual Functions of a Discrete Segment of the Integrin .beta..sub.3 Subunit: Cation Displacement Is Involved in Ligand Binding," Cell 79:659-667 (1994).
D'Souza et al., "Localization of an Arg-Gly-Asp Recognition Site Within an Integrin Adhesion Receptor," Science 242:91-93 (1988).
D'Souza et al., "Chemical Cross-linking of Arginyl-Glycyl-Aspartic Acid Peptides to an Adhesion Receptor of Platelets," J. Biol. Chem. 263: 3943-3951 (1988).
Edgington, "How Sweet It Is: Selectin-Mediating Drugs," Bio/Technology 10:383-389 (1992).
Ginsberg et al., "Divalent Cation Regulation of the Surface Orientation of Platelet Membrane Glycoprotein IIb," J. Clin. Invest. 78:1103-1111 (1986).
Haas and Plow, "Integrin-ligand interactions: A Year in Review," Curr. Opin. in Cell Biol., 6:656-662 (1994).
Hynes, "Integrins: Versatility, Modulation, and Signaling in Cell Adhesion," Cell 69:11-25 (1992).
Koivunen et al., "Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD Directed Integrins," Bio/Technology 13:265-270 (1995).
Loftus et al., "A .beta..sub.3 Integrin Mutation Abolished Ligand Binding and Alters Divalent Cation-Dependent Conformation," Science 249:915-918 (1990).
Marder, "Ligand Interactions with the RGD Recognition Site Alter Binding of GPIIb-IIIa Reactive Monoclonal Antibody to Human Platelets," Biochem. Biophys. Res. Comm. 195(2):799-806 (1993).
Bajt and Loftus, "Mutation of a Ligand Binding Domain of .beta..sub.3 Integrin," J. Biol. Chem. 269: 20913-20919 (1994).
Bajt et al., "A Spontaneous Mutation of Integrin .alpha..sub.IIb .beta..sub.3 (Platelet Glycoprotein IIb-IIIa) Helps Define a Ligand Binding Site," J. Biol. Chem. 267: 3789-3794 (1992).
Calvete et al., "Proteolytic degradation of the RGD-binding and non-RGD-binding conformers of human platelet integrin glycoprotein IIb/IIIa: clues for identification of regions involved in the receptor's activation," Biochem. J. 298:1-7 (1994).
Charo et al., "Inhibition of Fibrinogen Binding to GP IIb-IIIa by a GP IIIa Peptide," J. Biol. Chem. 266: 1415-1421 (1991).
Tuckwell et al., "Homology Modelling of Integrin EF-hands," Biochem. J. 285:325-331 (1992).
Vezenkov, "Peptides Containing the Arg-Gly-Asp Sequence as Inhibitiors of Platelet Aggregation: A Review," Bulg. Chem. Commun. 26:292-300 (1993).
Wood and Wetzel, "Novel cyclization chemistry especially suited for biologically derived, unprotected peptides," Int J. Peptide Protein Res. 39:533-539 (1992).

Affiliated with

Also associated with

Rating

Structural mimics of RGD-binding sites does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Structural mimics of RGD-binding sites, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Structural mimics of RGD-binding sites will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-81351